Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
 
 

Chalazion: Diagnosis and Differentials

Author Information and Disclosures

Contents

Clinical

History: A chalazion is usually a painless swelling on the eyelid that has been present for weeks to months. Patients may seek medical attention when a chalazion causes impaired vision, double vision, discomfort, or pain or becomes inflamed and painful, or infected.
  • The chief complaint must be examined in a thorough manner including questions concerning location, onset, duration, intensity, exacerbating and mitigating factors, previous intervention, and evaluation.
  • Changes in visual acuity must be clearly documented.
  • As the world becomes flatter, and intercontinental travel becomes easier, querying the patient about a travel history, particularly to locations known to be sources of leishmaniasis, is important.

    • Leishmaniasis is found in rain forests in Central America and South America to deserts in West Asia.

    • Leishmaniasis is found in some parts of Mexico and northern Argentina to southern Texas.

    • India, Bangladesh, Nepal, Sudan, and Brazil are the common sources of visceral leishmaniasis.

    • Leishmaniasis is not found in Australia or Oceania (ie, islands in the Pacific, including Melanesia, Micronesia, and Polynesia).

    • Leishmaniasis is not common in travelers to southern Europe or Southeast Asia.
  • Document recent viral infections.
  • Document immune competency status. Does the patient have frequent skin infections?
  • Ask about exposure or history of TB.

Physical: Completely examine the eye and conjunctival surface.

  • A chalazion is a palpable nodule on the eyelid.
  • Chalazia usually are nontender, nonerythematous, and nonfluctuant.
  • Invert the eyelid to visualize the palpebral conjunctiva and identify internal chalazia.
  • Chalazia may grow to 7-8 mm in diameter.
  • Injection of the conjunctiva is a common secondary finding.
  • Examine preauricular nodes to help determine infection.
  • No intraocular pathology should be found.
  • Presence of fever or distant nodes is not consistent with a chalazion.

Causes: Chalazia are associated with the following:

  • Seborrhea
  • Acne rosacea
  • Chronic blepharitis
  • High blood lipid concentrations (possible risk from increased blockage of sebaceous glands)
  • Leishmaniasis
  • TB
  • Immunodeficiency
  • Viral infection
  • Carcinoma

Differentials

Leishmaniasis
Tuberculosis


Other Problems to be Considered:

Blepharitis
Hyperimmunoglobulinemia E (hyper-IgE) syndrome
Meibomianitis
Meibomian cell carcinoma
Microcystic adnexal carcinoma
Plexiform neurofibroma
Sebaceous carcinoma
Squamous cell carcinoma
Staphylococcus aureus infection
Virus-induced infection

Workup

Lab Studies:

  • An uncomplicated chalazion diagnosis requires the provider to be certain the eyelid lesion is a sterile inflammation that will resolve with limited intervention. The caveat is that the provider must be sure of the diagnosis before initiating empiric chalazion therapy. A devastating delay in diagnosing carcinoma, TB, leishmaniasis, immune competency, or bacterial infection could occur if these conditions are masquerading as a chalazion. The provider must ensure that the patient has an adequate understanding of the typical progression of an uncomplicated chalazion: resolution within 1 month. Recurrent symptoms, refractive errors, or persistent lesions should prompt the provider to further investigate the lesion.
  • Fine-needle aspiration cytology of chalazia with atypical clinical presentation provides a means of documenting the diagnosis and excluding malignancy.
  • Viral and bacterial cultures can provide results to include or exclude an infectious etiology.
  • Visual acuity testing
  • Visual field testing
« Previous Page Section 2 of 4

Bibliography

  1. Aoki M, Kawana S: Bilateral chalazia of the lower eyelids associated with pulmonary tuberculosis. Acta Derm Venereol 2002; 82(5): 386-7[Medline].
  2. Berman JD: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997 Apr; 24(4): 684-703[Medline].
  3. Brookes JL, Bentley C, Verma S: Microcystic adnexal carcinoma masquerading as a chalazion. Br J Ophthalmol 1998 Feb; 82(2): 196-7[Medline].
  4. Crama N, Toolens AM, van der Meer JW: Giant chalazia in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. Eur J Ophthalmol 2004 May-Jun; 14(3): 258-60[Medline].
  5. De Silva DJ, Tumuluri K, Joshi N: Conjunctival squamous cell carcinoma: atypical presentation of HIV. Clin Experiment Ophthalmol 2005 Aug; 33(4): 419-20[Medline].
  6. Destafeno JJ, Kodsi SR, Primack JD: Recurrent Staphylococcus aureus chalazia in hyperimmunoglobulinemia E (Job's) syndrome. Am J Ophthalmol 2004 Dec; 138(6): 1057-8[Medline].
  7. Gershen HJ: Chalazion. In: Fraunfelder FT et al, eds. Current Ocular Therapy, 4. WB Saunders; 1995: 563-564.
  8. Ho SY, Lai JS: Subcutaneous steroid injection as treatment for chalazion: prospective case series. Hong Kong Med J 2002 Feb; 8(1): 18-20[Medline].
  9. Hosal BM, Zilelioglu G: Ocular complication of intralesional corticosteroid injection of a chalazion. Eur J Ophthalmol 2003 Nov-Dec; 13(9-10): 798-9[Medline].
  10. Khan JA, Doane JF, Grove AS: Sebaceous and meibomian carcinomas of the eyelid. Recognition, diagnosis, and management. Ophthal Plast Reconstr Surg 1991; 7(1): 61-6[Medline].
  11. Koo L, Hatton MP, Rubin PA: "Pseudo-pseudochalazion": Giant Chalazion Mimicking Eyelid Neoplasm. Ophthal Plast Reconstr Surg 2005 Sep; 21(5): 391-2[Medline].
  12. Litoff D, Balin MW: Ocular infections and inflammation. In: Catalano RA, ed. Ocular Emergencies. WB Saunders; 1992: 468-471.
  13. Mansour AM, Chan CC, Crawford MA: Virus-induced chalazion. Eye 2005 Mar 4;[Medline].
  14. Mustafa TA, Oriafage IH: Three methods of treatment of chalazia in children. Saudi Med J 2001 Nov; 22(11): 968-72[Medline].
  15. Palva J, Pohjanpelto PE: Intralesional corticosteroid injection for the treatment of chalazia. Acta Ophthalmologica 1983; 61: 933-937[Medline].
  16. Sadeghian G, Nilfroushzadeh MA, Moradi SH: Ocular leishmaniasis: a case report. Dermatol Online J 2005; 11(2): 19[Medline].
  17. Santa Cruz CS, Culotta T, Cohen EJ: Chalazion-induced hyperopia as a cause of decreased vision. Ophthalmic Surg Lasers 1997 Aug; 28(8): 683-4[Medline].
  18. Shields JA, Demirci H, Marr BP: Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004 Dec; 111(12): 2151-7[Medline].
  19. Smythe D, Hurwitz JJ, Tayfour F: The management of chalazion: a survey of Ontario ophthalmologists. Can J Ophthalmol 1990 Aug; 25(5): 252-5[Medline].

Chalazion excerpt

Author Information and Disclosures

Author: Jerome F.X. Naradzay, MD, FACEP, Emergency Services Medical Director, Department of Emergency Medicine, Maria Parham Medical Center

Coauthor(s): Sally Santen, MD, Program Director, Assistant Professor, Department of Emergency Medicine, Vanderbilt University

Jerome F.X. Naradzay, MD, FACEP, is a member of the following medical societies: American College of Emergency Physicians, and Society for Academic Emergency Medicine

Editor Information

Editor(s): David FM Brown, MD, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Vice-Chair, Department of Emergency Medicine, Massachusetts General Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Douglas Lavenburg, MD, Clinical Professor, Department of Emergency Medicine, Christiana Care Health Systems; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Barry Brenner, MD, PhD, FACEP, Professor of Emergency Medicine, Professor of Internal Medicine, and Professor of Anatomy and Neurobiology, Research Director, Department of Emergency Medicine, University of Arkansas for Medical Sciences

Related Articles
Patient Education
 
 
We subscribe to the
HONcode principles of the
Health On the Net Foundation
 
© 1996-2007 by WebMD
All Rights Reserved
DISCLAIMER:The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.